Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4
Go back to Lexicon (LXRX) Says Top-Line Results from LX4211 Study Show Enhanced Effects with DPP-4| Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) | Delayed: 2.34 +0.02 (0.86%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.32 | 52 Week High | $19.62 | |||
| Open | $2.35 | 52 Week Low | $7.65 | |||
| Day High | $2.37 | P/E | N/A | |||
| Day Low | $2.30 | EPS | $-0.22 | |||
| Volume | 1,346,464 | |||||
